Management Change3 Jul 2026, 07:10 pm
Bliss GVS Pharma Appoints New Director and CEO
AI Summary
Bliss GVS Pharma Ltd. announced significant management changes following a Board of Directors meeting on July 3, 2026. Mr. Santosh Parab has been appointed as an Additional Director (Non-Executive Non-Independent) effective July 3, 2026. Additionally, Mr. Rahul Adakmol will take over as the Chief Executive Officer from July 15, 2026. Mr. Narsimha Shibroor Kamath will step down as CEO on July 14, 2026, but will continue in his role as Managing Director. These appointments aim to strengthen the company's leadership and strategic direction.
Key Highlights
- Santosh Parab appointed as Additional Director (Non-Executive Non-Independent).
- Rahul Adakmol to assume role of Chief Executive Officer.
- Narsimha Shibroor Kamath transitions from CEO to Managing Director.
- Changes effective July 2026 to bolster leadership.
- Appointments follow recommendation from Nomination and Remuneration Committee.
Price Impact
More from BLISSGVS